Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Working Groups Hot Topics

PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives.

 This

This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please

email:

email workinggroups@phuse.global.

Image Removed

DT Winter Event 2023

The Data Transparency Winter Event 2023 will take place 7-9 February 2023. During this virtual event, presentations will be delivered across the three days in bitesize chunks from 15:00-17:30 (GMT).

Call for Speakers is open and closes 30 November! Make sure to submit your abstract in order to share your vital knowledge and experience with the wider data transparency community. To apply to present, please submit an abstract (maximum of 150 words) along with your presentation title to workinggroups@phuse.global

Image Removed

Q3/4 2022 Working Group ReportThe final Working Group report of 2022 is now live! Working Group reports are a great way of keeping up with the latest project updates and deliverables, as well as gaining an insight into what each Working Group has planned for the future. Click here to view the full Working Group report for Q3/4 2022. 

Optimizing the use of Data Standards Banner.jpgImage Removed

Call for Questions! 

Do you have an industry question you’ve always wanted to know the answer to? Why not ask SDTM ADaM Implementation FAQ! The aim of this project is to collect frequently asked questions, and to develop and review a response, sometimes collaborating with CDISC and FDA. The team will then publish their response on the PHUSE Advance Hub. If you have a question for the team, please submit it via workinggroups@phuse.global.

Recently Published Deliverables

Visit the PHUSE website to view the extensive list of all published deliverables.

Image Removed

Projects Calling for Volunteers

BIMO FAQ – It was apparent during the creation of the PHUSE Bioresearch Monitoring Data Reviewer's Guide (BDRG) that organisations implementing BIMO Submission packages have outstanding questions. The aim of this project is to develop a BIMO Frequently asked Questions Forum on the PHUSE Advance Hub. The forum will utilise the questions brought forward by the pharma/CRO community via public review, presentations, PHUSE BIMO team members, etc...
To get involved, please contact workinggroups@phuse.global


PHUSE/FDA CSS 2024

Registration for the PHUSE/FDA CSS 2024 is open!

Come and be a part of the PHUSE/FDA Computational Science Symposium 2024 (CSS) taking place 3–5 June in Silver Spring, MD. Share your insights, discoveries and solutions with the PHUSE Community, who are eager to learn and collaborate. 

Status
colourBlue
titleRegister Here


Calling For Feedback

The Good Transparency Practices project within the Data Transparency Working Group, is now calling for feedback! This White Paper aims to define a set of best practices for data transparency and create a Good Transparency Practices guidance. The best practices will aim to ensure anonymised data is compliant with the legal requirements as defined by Regulators, as well as preserves as much data utility as possible.

Please send in your comments to workinggroups@phuse.global by 3 May.



New Deliverables

Image Added

The Best Data Practices for Rare Disease Patient Foundations and Researchers within the Real World Evidence Working Group, has published a new deliverable in the form of a poster. The poster provides an overview of Ensuring Registry Data Relevance and Reliability for Regulatory Use

The PHUSE data standards community, which is comprised of leaders and experts responsible for the governance and implementation of data standards across the biopharmaceutical industry, have authored and new White Paper. The Data Standards White Paper highlights current challenges in data standardisation across the biopharma industry and identify opportunities where we can work together to tackle them.


The SDTM ADaM Implementation FAQ within Optimizing the Use of Data Standards Working Group have published a new FAQ! The question they have answered is 'Naming Convention for Split RS Domain', you can view this question and the teams response viaValidation/Conformance Rules page. You can see all the FAQ this project has answered so far via here.

Do you have a SDTM ADaM question? You can send your questions to the team by emailing workinggroups@phuse.global.


Volunteer Opportunities

Image Added

The Data Visualisation & Open Source Technology Working Group has a new project, Demonstrating Real-World Impact of Modernization of Statistical Analytics (MSA) Framework.This project aims to extend the MSA framework by creating a reference architecture that takes into account real-world scenarios and design solutions to remediate them, ultimately providing a practical guide to building an end-to-end validated environment for regulated work. Companies seeking to build an open-source programming environment for regulatory reporting can leverage the MSA framework for guidance. However, since the framework is designed to be both flexible and extensible, implementing it may prove challenging for companies, resulting in situations where risks are not sufficiently mitigated. While the original MSA paper provided conceptual guidance, the PHUSE handover of the project will seek to provide an overview of practical implementations of the framework being applied.

This project is calling for volunteers, to join contact workinggroups@phuse.global by 26 April.


The Safety Analytics Working Group is looking for a new Working Group Lead to join their team. This Working Group is a cross-disciplinary collaboration working to improve the content and implementation of clinical trial safety analyses for medical research, leading to better data interpretations and increased efficiency in the clinical drug development and review processes.

Click here to see a list of current projects within this Working Group.

Learn more about the roles and the responsibilities of a Working Group Lead and apply by emailing workinggroups@phuse.global. Closing date 26 April.


Multiple projects within Working Groups are open to join. PHUSE welcomes new members who can apply their knowledge to bring fresh ideas and contribute to the ongoing work of PHUSE projects. For more information, click here, read the Welcome Pack or email workinggroups@phuse.global


PHUSE Communications 

Working Groups Report: Includes

Project Idea?

Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug, biologic and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements: 

  • The projects must address significant research issues relevant to Computational Science
  • The project must not attempt to address FDA policy issues
  • There must be at least one Project Lead personally involved in planning and carrying out the project

New projects can be submitted anytime during the year, click here to submit. 

the bought
PHUSE Communications 
Working Groups Latest Report Q3/4 2022: The report includes

project updates, recent and upcoming deliverables and

the

future plans for each Working Group.

Monthly Mailings:Our The monthly newsletter. Here  you you will find a  full full update from each month of the year, easily accessible and divided into key areas of PHUSE.

PHUSE Blogs: Fancy a quick read? A blog is

a perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics

brought to you by industry professionals


New Project Idea? 

Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug, biological and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements: 

  • The projects must address significant research issues relevant to Computational Science
  • The project must not attempt to address FDA policy issues
  • There must be at least one Project Lead personally involved in planning and carrying out the project

New projects can be submitted anytime during the year, click here to submit